World Wires · story 17044 · unverified · 1 source(s)

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology compan

Open in the desk

Coverage

• Spyre Therapeutics Announces Grants of Inducement Awards GlobeNewswire: public companies · tier D · clear net · 2026-10-02 20:05 UTC

What this site indexes